tirzepatide for heart failure with preserved ejection fraction and obesity In the SUMMIT trial, researchers examined cardiovascular outcomes of treatment in patients with with obesity. Full trial results and Plain Language Summary: https://nej.md/4hRGaTY Medthreads Tirzepatide benefits obese HFpEF patients

Beardsall K, Ogilvy-Stuart AL, Frystyk J, et al

For pelvic fractures the rates were higher in women (0.3% vs

They dont suppress your appetite directly but can give you more energy, which can motivate you to stay active and stick with your weight loss plan

The difference in SF-36 score changes from the score measured at the baseline to that at 90 days between the acetyl-L-carnitine group and placebo group was 4.85, and the standard deviation was presumed to be 10 based on these results

GLP-1 fatigue is a recognized side effect that can significantly reduce both structured exercise and daily movement

A key limitation is that the analysis was limited in controlling for factors that differ between studies